Our data demonstrate that the expression and activity of molecules involved in maintaining and remodelling neuromuscular phenotype, including AMPK and p38, were unchanged in skeletal muscle during the manifestation and progression of SMA‐like symptoms, while others such as PGC‐1α were depressed coincident with increased disease severity. This evidence concerns the gene PPARGC1A and proximal spinal muscular atrophy.